477 related articles for article (PubMed ID: 26493127)
21. Relapsing-Remitting Multiple Sclerosis diagnosis from cerebrospinal fluids via Fourier transform infrared spectroscopy coupled with multivariate analysis.
Yonar D; Ocek L; Tiftikcioglu BI; Zorlu Y; Severcan F
Sci Rep; 2018 Jan; 8(1):1025. PubMed ID: 29348591
[TBL] [Abstract][Full Text] [Related]
22. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
[TBL] [Abstract][Full Text] [Related]
23. The association of intrathecal immunoglobulin synthesis and cortical lesions predicts disease activity in clinically isolated syndrome and early relapsing-remitting multiple sclerosis.
Calabrese M; Federle L; Bernardi V; Rinaldi F; Favaretto A; Varagnolo MC; Perini P; Plebani M; Gallo P
Mult Scler; 2012 Feb; 18(2):174-80. PubMed ID: 21868488
[TBL] [Abstract][Full Text] [Related]
24. Complement activation in cerebrospinal fluid in clinically isolated syndrome and early stages of relapsing remitting multiple sclerosis.
Håkansson I; Ernerudh J; Vrethem M; Dahle C; Ekdahl KN
J Neuroimmunol; 2020 Mar; 340():577147. PubMed ID: 31951875
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of the 2017 McDonald criteria in patients with a first demyelinating event suggestive of relapsing-remitting multiple sclerosis.
Lee DH; Peschke M; Utz KS; Linker RA
Eur J Neurol; 2019 Mar; 26(3):540-545. PubMed ID: 30362206
[TBL] [Abstract][Full Text] [Related]
27. CXCL10 and CXCL13 chemokines in patients with relapsing remitting and primary progressive multiple sclerosis.
Iwanowski P; Losy J; Kramer L; Wójcicka M; Kaufman E
J Neurol Sci; 2017 Sep; 380():22-26. PubMed ID: 28870573
[TBL] [Abstract][Full Text] [Related]
28. Neurofilament light chain and oligoclonal bands are prognostic biomarkers in radiologically isolated syndrome.
Matute-Blanch C; Villar LM; Álvarez-Cermeño JC; Rejdak K; Evdoshenko E; Makshakov G; Nazarov V; Lapin S; Midaglia L; Vidal-Jordana A; Drulovic J; García-Merino A; Sánchez-López AJ; Havrdova E; Saiz A; Llufriu S; Alvarez-Lafuente R; Schroeder I; Zettl UK; Galimberti D; Ramió-Torrentà L; Robles R; Quintana E; Hegen H; Deisenhammer F; Río J; Tintoré M; Sánchez A; Montalban X; Comabella M
Brain; 2018 Apr; 141(4):1085-1093. PubMed ID: 29452342
[TBL] [Abstract][Full Text] [Related]
29. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
[TBL] [Abstract][Full Text] [Related]
30. Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study.
Haghikia A; Haghikia A; Hellwig K; Baraniskin A; Holzmann A; Décard BF; Thum T; Gold R
Neurology; 2012 Nov; 79(22):2166-70. PubMed ID: 23077021
[TBL] [Abstract][Full Text] [Related]
31. Differential microRNA expression in blood in multiple sclerosis.
Søndergaard HB; Hesse D; Krakauer M; Sørensen PS; Sellebjerg F
Mult Scler; 2013 Dec; 19(14):1849-57. PubMed ID: 23773985
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal K free light chain synthesis in multiple sclerosis at clinical onset associates with local IgG production and improves the diagnostic value of cerebrospinal fluid examination.
Puthenparampil M; Altinier S; Stropparo E; Zywicki S; Poggiali D; Cazzola C; Toffanin E; Ruggero S; Grassivaro F; Zaninotto M; Plebani M; Gallo P
Mult Scler Relat Disord; 2018 Oct; 25():241-245. PubMed ID: 30130707
[TBL] [Abstract][Full Text] [Related]
33. The patients with clinically isolated syndrome and relapsing remitting multiple sclerosis show different levels of advanced protein oxidation products and total thiol content in plasma and CSF.
Ljubisavljevic S; Stojanovic I; Vojinovic S; Stojanov D; Stojanovic S; Cvetkovic T; Savic D; Pavlovic D
Neurochem Int; 2013 Jun; 62(7):988-97. PubMed ID: 23500606
[TBL] [Abstract][Full Text] [Related]
34. Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.
Sola P; Mandrioli J; Simone AM; Ferraro D; Bedin R; Annecca R; Venneri MG; Nichelli PF; Merelli E
Mult Scler; 2011 Mar; 17(3):303-11. PubMed ID: 21078694
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of cerebrospinal fluid analysis at the time of a first demyelinating event.
Gout O; Bouchareine A; Moulignier A; Deschamps R; Papeix C; Gorochov G; Héran F; Bastuji-Garin S
Mult Scler; 2011 Feb; 17(2):164-72. PubMed ID: 20965960
[TBL] [Abstract][Full Text] [Related]
36. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid.
Timirci-Kahraman O; Karaaslan Z; Tuzun E; Kurtuncu M; Baykal AT; Gunduz T; Tuzuner MB; Akgun E; Gurel B; Eraksoy M; Kucukali CI
Acta Neurol Belg; 2019 Mar; 119(1):101-111. PubMed ID: 29873030
[TBL] [Abstract][Full Text] [Related]
37. Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Novakova L; Axelsson M; Khademi M; Zetterberg H; Blennow K; Malmeström C; Piehl F; Olsson T; Lycke J
J Neurochem; 2017 Apr; 141(2):296-304. PubMed ID: 27787906
[TBL] [Abstract][Full Text] [Related]
38. Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing-remitting MS.
Novakova L; Singh AK; Axelsson M; Ståhlman M; Adiels M; Malmeström C; Zetterberg H; Borén J; Lycke J; Cardell SL; Blomqvist M
J Neurochem; 2018 Aug; 146(3):322-332. PubMed ID: 29676479
[TBL] [Abstract][Full Text] [Related]
39. Histogram analysis of quantitative T1 and MT maps from ultrahigh field MRI in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Al-Radaideh A; Mougin OE; Lim SY; Chou IJ; Constantinescu CS; Gowland P
NMR Biomed; 2015 Nov; 28(11):1374-82. PubMed ID: 26346925
[TBL] [Abstract][Full Text] [Related]
40. The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Blauth K; Zhang X; Chopra M; Rogan S; Markovic-Plese S
Clin Immunol; 2015 Apr; 157(2):121-32. PubMed ID: 25596452
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
